Laxman became CEO of RB, a FTSE 15 company, in
September 2019. As a global leader in Health,
Hygiene and Nutrition, RB’s brands are found in more
than 190 countries. It has annual revenues of
approximately £13BN and employs 42,000 colleagues
globally.
20 million times a day RB brands are selected by
consumers, who rely on the company’s 200-year
strong heritage. This stable of trusted global brands
includes: Enfamil, Nutramigen, Nurofen, Strepsils,
Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol,
Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite, Air Wick and more
Under Laxman’s leadership, RB’s purpose is to protect, heal and nurture in a relentless pursuit of a
cleaner, healthier world. RB fights to make access to the highest-quality hygiene, wellness and
nourishment a right, not a privilege, for everyone.
Prior to joining the company, Laxman held various roles at PepsiCo from 2012 to 2019. He was
previously Global Chief Commercial Officer, with responsibility for R&D, categories, e-commerce,
design, go-to-market, global customers and strategy.
Before this, Laxman served as the Chief Executive Officer of PepsiCo’s Latin America, Europe and SubSaharan Africa operations, where he ran the company's food and beverage businesses across over
100 countries. He also spent time as CEO of PepsiCo Latin America and as the CFO of PepsiCo
Americas Foods, which was responsible for half of the company’s profits.
Prior to PepsiCo, Laxman served as a Director for McKinsey & Company and held various key global
roles from 1993 to 2012. He is a Trustee of the Brookings Institution and a member of the Council on
Foreign Relations.